150 related articles for article (PubMed ID: 32207661)
21. PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study.
Poteat T; Malik M; van der Merwe LLA; Cloete A; Adams D; Nonyane BAS; Wirtz AL
Lancet HIV; 2020 Dec; 7(12):e825-e834. PubMed ID: 32622370
[TBL] [Abstract][Full Text] [Related]
22. Perceptions of and interest in HIV pre-exposure prophylaxis use among adolescent girls and young women in Lilongwe, Malawi.
Maseko B; Hill LM; Phanga T; Bhushan N; Vansia D; Kamtsendero L; Pettifor AE; Bekker LG; Hosseinipour MC; Rosenberg NE
PLoS One; 2020; 15(1):e0226062. PubMed ID: 31929547
[TBL] [Abstract][Full Text] [Related]
23. Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States.
Bazzi AR; Leech AA; Biancarelli DL; Sullivan M; Drainoni ML
AIDS Patient Care STDS; 2017 Aug; 31(8):348-355. PubMed ID: 28719229
[TBL] [Abstract][Full Text] [Related]
24. Symptoms of post-traumatic stress and associations with sexual behaviour and PrEP preferences among young people in South Africa, Uganda and Zimbabwe.
Webb EL; Dietrich JJ; Ssemata AS; Nematadzira TG; Hornschuh S; Kakande A; Tshabalala G; Muhumuza R; Mutonyi G; Atujuna M; Bere T; Bekker LG; Abas MA; Weiss HA; Seeley J; Stranix-Chibanda L; Fox J;
BMC Infect Dis; 2022 May; 22(1):466. PubMed ID: 35578175
[TBL] [Abstract][Full Text] [Related]
25. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.
Velloza J; Khoza N; Scorgie F; Chitukuta M; Mutero P; Mutiti K; Mangxilana N; Nobula L; Bulterys MA; Atujuna M; Hosek S; Heffron R; Bekker LG; Mgodi N; Chirenje M; Celum C; Delany-Moretlwe S;
J Int AIDS Soc; 2020 Mar; 23(3):e25463. PubMed ID: 32144874
[TBL] [Abstract][Full Text] [Related]
26. The PrEPARE Pretoria Project: protocol for a cluster-randomized factorial-design trial to prevent HIV with PrEP among adolescent girls and young women in Tshwane, South Africa.
Wechsberg WM; Browne FA; Ndirangu J; Bonner CP; Minnis AM; Nyblade L; Speizer IS; Howard BN; Myers B; Ahmed K
BMC Public Health; 2020 Sep; 20(1):1403. PubMed ID: 32933510
[TBL] [Abstract][Full Text] [Related]
27. Male partners' influence on women's acceptance and use of PrEP products across two high HIV-burdened districts in South Africa.
Mbewe L; Govender E
Afr J AIDS Res; 2020 Jul; 19(2):93-100. PubMed ID: 32320329
[TBL] [Abstract][Full Text] [Related]
28. Understanding willingness to use oral pre-exposure prophylaxis for HIV prevention among men who have sex with men in China.
Wang X; Bourne A; Liu P; Sun J; Cai T; Mburu G; Cassolato M; Wang B; Zhou W
PLoS One; 2018; 13(6):e0199525. PubMed ID: 29928008
[TBL] [Abstract][Full Text] [Related]
29. PrEP reminds me that I am the one to take responsibility of my life: a qualitative study exploring experiences of and attitudes towards pre-exposure prophylaxis use by women in Eswatini.
Bjertrup PJ; Mmema N; Dlamini V; Ciglenecki I; Mpala Q; Matse S; Kerschberger B; Wringe A
BMC Public Health; 2021 Apr; 21(1):727. PubMed ID: 33853575
[TBL] [Abstract][Full Text] [Related]
30. The potential effect of pre-exposure prophylaxis (PrEP) roll-out on sexual-risk behaviour among adolescents and young people in East and southern Africa.
Ssemata AS; Muhumuza R; Stranix-Chibanda L; Nematadzira T; Ahmed N; Hornschuh S; Dietrich JJ; Tshabalala G; Atujuna M; Ndekezi D; Nalubega P; Awino E; Weiss HA; Fox J; Seeley J
Afr J AIDS Res; 2022 Mar; 21(1):1-7. PubMed ID: 35361057
[TBL] [Abstract][Full Text] [Related]
31. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
[TBL] [Abstract][Full Text] [Related]
32. The Pre-Exposure Prophylaxis-Stigma Paradox: Learning from Canada's First Wave of PrEP Users.
Grace D; Jollimore J; MacPherson P; Strang MJP; Tan DHS
AIDS Patient Care STDS; 2018 Jan; 32(1):24-30. PubMed ID: 29185801
[TBL] [Abstract][Full Text] [Related]
33. Willingness to use pre-exposure prophylaxis for HIV prevention among men who have sex with men in Malaysia: Findings from an online survey.
Lim SH; Mburu G; Bourne A; Pang J; Wickersham JA; Wei CKT; Yee IA; Wang B; Cassolato M; Azwa I
PLoS One; 2017; 12(9):e0182838. PubMed ID: 28902857
[TBL] [Abstract][Full Text] [Related]
34. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
[TBL] [Abstract][Full Text] [Related]
35. Willingness to use and have sex with men taking HIV pre-exposure prophylaxis (PrEP): results of online surveys of Australian gay and bisexual men, 2011-2015.
Holt M; Lea T; Schmidt HM; Kolstee J; Ellard J; Murphy D; Truong HH; de Wit J
Sex Transm Infect; 2017 Sep; 93(6):438-444. PubMed ID: 28108701
[TBL] [Abstract][Full Text] [Related]
36. A qualitative study to identify critical attributes and attribute-levels for a discrete choice experiment on oral pre-exposure prophylaxis (PrEP) delivery among young people in Cape Town and Johannesburg, South Africa.
Dietrich JJ; Atujuna M; Tshabalala G; Hornschuh S; Mulaudzi M; Koh M; Ahmed N; Muhumuza R; Ssemata AS; Otwombe K; Bekker LG; Seeley J; Martinson NA; Terris-Prestholt F; Fox J
BMC Health Serv Res; 2021 Jan; 21(1):17. PubMed ID: 33407395
[TBL] [Abstract][Full Text] [Related]
37. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
[TBL] [Abstract][Full Text] [Related]
38. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study.
Laurent C; Dembélé Keita B; Yaya I; Le Guicher G; Sagaon-Teyssier L; Agboyibor MK; Coulibaly A; Traoré I; Malan JB; De Baetselier I; Eubanks A; Riegel L; Rojas Castro D; Fayé-Ketté H; Koné A; Diandé S; Dagnra CA; Serrano L; Diallo F; Mensah E; Dah TTE; Anoma C; Vuylsteke B; Spire B;
Lancet HIV; 2021 Jul; 8(7):e420-e428. PubMed ID: 34048794
[TBL] [Abstract][Full Text] [Related]
39. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H;
PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
[TBL] [Abstract][Full Text] [Related]
40. Community perspectives on barriers and challenges to HIV pre-exposure prophylaxis access by men who have sex with men and female sex workers access in Nigeria.
Emmanuel G; Folayan M; Undelikwe G; Ochonye B; Jayeoba T; Yusuf A; Aiwonodagbon B; Bilali C; Umoh P; Ojemeiri K; Kalaiwo A
BMC Public Health; 2020 Jan; 20(1):69. PubMed ID: 31941469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
